Reduction of Initial AHI

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MEDARTIS
MEDARTISSwitzerland - Basel
1 program
The IMD is a resilient palatal implant which is introduced through a stab incision into the palate.N/A1 trial
Active Trials
NCT02094482CompletedEst. Oct 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MEDARTISThe IMD is a resilient palatal implant which is introduced through a stab incision into the palate.

Clinical Trials (1)

NCT02094482MEDARTISThe IMD is a resilient palatal implant which is introduced through a stab incision into the palate.

Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)

Start: Apr 2014Est. completion: Oct 2020
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space